Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Foley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Lancet. Oncology|August 4, 2004
Gene-based therapy in prostate cancerRuth Foley, Mark Lawler, Donal Hollywood
Endocrine-Related Cancer|September 17, 2004
Molecular pathology of prostate cancer: the key to identifying new biomarkers of diseaseRuth Foley, Donal Hollywood, Mark Lawler
Clinics in Dermatology|March 10, 2017
Demodex and rosacea revisitedEllen M Moran, Ruth Foley, Frank C Powell
Endocrine-Related Cancer|May 27, 2006
The emerging roles of DNA methylation in the clinical management of prostate cancerAntoinette S Perry, Ruth Foley, Karen Woodson, et al.
The Prostate|October 15, 2010
Androgen hypersensitivity in prostate cancer: molecular perspectives on androgen deprivation therapy strategiesRuth Foley, Laure Marignol, John P Keane, et al.
The Prostate|October 15, 2010
Comment on "Androgen-hypersensitive preclinical model of prostate cancer" by Kawata et alRuth Foley, Laure Marignol, John P Keane, et al.
The Journal of Gene Medicine|December 4, 2008
Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitroLaure Marignol, Ruth Foley, Thomas D Southgate, et al.
Cancer Treatment Reviews|April 13, 2011
Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patientsAlice Vajda, Laure Marignol, Ruth Foley, et al.
Journal of Materials Chemistry. B|July 25, 2021
Reactive oxygen species (ROS): utilizing injectable antioxidative hydrogels and ROS-producing therapies to manage the double-edged swordZhonglei He, Qian Xu, Ben Newland, et al.
ACS Macro Letters|May 23, 2023
Branch Unit Distribution Matters for Gene DeliveryYinghao Li, Zhonglei He, Xianqing Wang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Lancet. Oncology|August 4, 2004
Gene-based therapy in prostate cancerRuth Foley, Mark Lawler, Donal Hollywood
Endocrine-Related Cancer|September 17, 2004
Molecular pathology of prostate cancer: the key to identifying new biomarkers of diseaseRuth Foley, Donal Hollywood, Mark Lawler
Clinics in Dermatology|March 10, 2017
Demodex and rosacea revisitedEllen M Moran, Ruth Foley, Frank C Powell
Endocrine-Related Cancer|May 27, 2006
The emerging roles of DNA methylation in the clinical management of prostate cancerAntoinette S Perry, Ruth Foley, Karen Woodson, et al.
The Prostate|October 15, 2010
Androgen hypersensitivity in prostate cancer: molecular perspectives on androgen deprivation therapy strategiesRuth Foley, Laure Marignol, John P Keane, et al.
The Prostate|October 15, 2010
Comment on "Androgen-hypersensitive preclinical model of prostate cancer" by Kawata et alRuth Foley, Laure Marignol, John P Keane, et al.
The Journal of Gene Medicine|December 4, 2008
Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitroLaure Marignol, Ruth Foley, Thomas D Southgate, et al.
Cancer Treatment Reviews|April 13, 2011
Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patientsAlice Vajda, Laure Marignol, Ruth Foley, et al.
Journal of Materials Chemistry. B|July 25, 2021
Reactive oxygen species (ROS): utilizing injectable antioxidative hydrogels and ROS-producing therapies to manage the double-edged swordZhonglei He, Qian Xu, Ben Newland, et al.
ACS Macro Letters|May 23, 2023
Branch Unit Distribution Matters for Gene DeliveryYinghao Li, Zhonglei He, Xianqing Wang, et al.
Pageof 2